CANNABIS BUSINESSES FOR SALE

Two fully licensed, fully built-out cannabis retail stores in Ontario generated $300K EBITDA in 2025 and projected to exceed $2M in 2026 gross sales

A rare opportunity to acquire a fully licensed, debt-free cannabis enterprise in QC with $11.5M in 2025 revenue, dual international export certifications, and turnkey access to the Quebec market. The sale includes all Health Canada licences, brand IP, equipment, and leasehold operational infrastructure.

Pre-revenue, fully permitted German manufacturing asset offering strategic buyers a turnkey EU-GMP designed production facility with advanced cleanroom infrastructure and pharmaceutical-grade capabilities positioned to capture the emerging European regulated cannabis and specialty medicines market.

Opportunity to acquire, invest in, restructure, or refinance a licensed cannabis cultivation, processing, branded products, & medical cannabis platform through a Court-approved Sale & Investment Solicitation Process (SISP). This offering provides a potential "clean slate" entry into the Canadian & global cannabis markets through a debt-free acquisition structure.

Unique opportunity to acquire a fully operational, profitable e-health platform serving medical cannabis patients across Germany through an integrated online consultation, prescription, and pharmacy fulfilment model.

Fully licensed, profitable German medical cannabis platform providing immediate market access, certified warehouse/storage facility, and high-margin EU-GMP manufacturing capabilities

Opportunity to acquire a turnkey, fully built, turnkey 4,800 sq ft micro-cultivation facility in AB, offered at a significant discount to replacement cost

Innovative, licensed cannabis processor driving efficient distribution, secure storage & market expansion nationwide seeks full sale. Open for strategic equity partner.

Fully licensed & profitable German medical cannabis distributor offers an integrated, EU-GDP compliant platform for immediate market access and a gateway to EU-GMP processing, with €9M revenue in 2025 with €10.8M projected in 2026

GACP-certified, ~65,000 ft.², wholly-owned, custom-designed cannabis greenhouse & state-of-the-art processing facility, with an expansive outdoor cultivation area poised for high volume cannabis production

Exceptional opportunity to acquire a leased, purpose-designed, 10,000 ft.² indoor licensed processing facility located in a multi-unit industrial complex, situated in Toronto

A reputable Colombian medical cannabis enterprise, renowned for its consistent year-round production of quality cannabis at a significant scale, is actively seeking a strategic equity partner

Fully licensed, state-of-the-art, 20,000 sq. ft. cannabis production facility on 56 acres just 1.5 hours from Montreal, Quebec. Site offers 1,200 KG annual production capacity, and includes licenses, equipment, and real estate, providing ample expansion potential, advanced security, and high-efficiency operational systems, strategically located near major distribution channels

Established EU-GMP-certified cannabis company in Portugal with state-of-the-art indoor cultivation facility seeking strategic equity partner to support its next phase of growth.

A Swiss cannabis cultivator and processor, supplying premium cannabis flowers and extracts to the pharmaceutical market, is seeking a strategic equity partner to fuel its continued growth. Positioned to become a leading player in the European cannabis industry, the company is primed for rapid expansion.

Multi-licensed, dominant medical cannabis producer, importer and distributor in Peru with Telehealth clinic, focused on premium cannabis products, with established sales and distribution channels, poised to become a dominant leader in the Peruvian and South American medical cannabis sector

Disruptive, Australian Telehealth provider and virtual medical clinic with industry-first, Omni-Channel Medical Cannabis Marketplace for patients, doctors, pharmacies, distributors and product suppliers seeks strategic investment partner looking to enter/expand in the Australian market

Leading medical cannabis Telehealth & market authorisation service provider in Poland with established sales and distribution channels offers optimal route to the Polish market, building on 15% current market share!

Danish European Market player seeks partner to takeover and further expand existing facility and operations due to strategy change in their way forward

Amazing opportunity to enter the CBD market with one of the top CBD Brands in Germany. Opportunity comprised of two stores, established e-commerce platform, multiple brands, and diversified, natural and organic CBD products

A turnkey mobile extraction solution provider with EU GMP certifiable, proprietary laboratories for hemp and cannabis producers seeks strategic investment partner

Brand new, Dutch-style Venlo glass greenhouse manufactured by Havecon with 350,000 ft.² or over 8 acres in size for sale (valued at $18 million USD) that can be erected anywhere globally

Expansion-ready licensed micro cultivation facility on 32 acres offers low-cost entry into highly desirable Quebec market. Owner seeks full divestiture of the going-concern business, equipment and lease.

An operating cannabis brand in Northern Alberta — 40 minutes from the AGLC warehouse — with 18 AGLC-approved SKUs, and a 6,000 sq ft licensed facility, available as a $350,000 asset sale of brand, inventory, and lease.

Provincial-licensed retail cannabis package in ON featuring an active, operating storefront and a fully built-out former retail footprint, offered at an accessible price point for an incoming operator.

~4,000 ft.² indoor, standalone and owned micro-cultivation and processing facility situated on 1.01 acres in Saskatchewan. The sale includes the operating company, real estate, unencumbered equipment, established brands, genetics and qualifying inventory for $700K OBO.

Opportunity to acquire a fully built-out, cannabis cultivation buildings located 30 minutes east of Montreal, featuring two purpose-built cultivation and nursery buildings on 23 acres for 1.7M o.b.o

Acquire a "Top-Tier" global export hub at a 40% discount to invested capital. Secure a 36-month shortcut to market leadership with a turnkey, debt-free operation featuring €0.30/g production costs, an active EU offtake agreement, and proven export channels to Tier-1 markets.

A licensed, operational, GDP-aligned pharmaceutical wholesaler in Poland providing immediate market access for medical cannabis through established distribution channels and controlled-substance authorizations. Company seeks a 51% to 100% equity sale.

Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.

Unique opportunity to acquire a fully remote telemedicine and digital prescription, GDPR-compliant platform operating under the EU cross-border framework. The business connects over 25,000 patients with licensed doctors and pharmacies in Germany

A rare opportunity to acquire a turnkey, GACP-certified, fully licensed cannabis operation comprised of two indoor facilities in a prime Hamilton-area location, capable of 3,000 KG annual production with expansion potential. The sale includes all Health Canada licences, real estate, and equipment.

Outright sale of a ~36,000 ft.² operational facility, including all licences, real estate, and high-value equipment for seamless takeover.

Canadian online wellness and telehealth platform delivering integrative medicine and cannabis-enabled care, with $3.9M annual revenue and $1.9M EBITDA — supported by national clinician coverage, VAC billing expertise, and a lean, 100% virtual model

Purpose-built, fully owned ~50,000 sq. ft. GACP & EU-GMP designed cannabis cultivation and processing facility situated on 12 acres of land within 1.5 hours of the GTA. Featuring robust infrastructure and a flexible layout with cultivation areas designed to meet GACP standards (highly processed), and the processing area built to EU-GMP specifications, the property is available for lease or outright sale.

This purpose-built cannabis cultivation and processing facility, situated 1 hour west of the GTA, covers 10,000 sq. ft. on 5 acres of land and features multiple specialized rooms for cultivation and processing. The seller is seeking a full sale of both the land and the building.

Opportunity to acquire a Portuguese turnkey pre-licence project with a 2,000m² facility plan on a 10,000m² plot. Includes pre-licences, strategic location, renegotiated agreements, pre-approved plans, and scalable Spanish and German subsidiaries.

Cannabis API manufacturer in EU-GMP certified pharma facility with expert team ready to lead the 2,000 KG/yr medical cannabis market in Italy

State of the art, low-cost manufacturing facility in North Macedonia with access to the supply chain and contracts in place seeks full sale. Poised to drive value creation in the rapidly growing global medicinal cannabis market.

Hybrid indoor/outdoor year-round cultivator with hand-picked genetics producing high quality flower/biomass at industry-low prices

Largest licensed cultivator in Africa! GACP, IMC-GAP, strong South Africa and U.S.-based ownership group, high-THC cultivars and industry-low cost structure will allow this global cannabis company to thrive under future price compression

An opportunity to acquire a fully licensed German pharmaceutical distributor purpose-built for the medical cannabis sector. The company operates under a lean, light-touch model leveraging outsourced logistics, compliance, and quality management partners, providing an efficient and scalable foundation for rapid market entry

Well-established German medical cannabis distributor with sales network into German pharmacies & other global markets is seeking a strategic equity partner to fuel expansion plans. Open for full divestiture.

A privately held, well established European cannabis company specializing in the cannabis value chain from seed to sale, including R&D, product formulation, manufacturing, B2B & B2C sales, distribution of cannabis raw materials, retail & branding

Scalable, purpose-built licensed cultivation & processing facility in Saskatchewan offers turnkey opportunity at an affordable price

Rare opportunity to acquire an EU-GMP-certified Canadian cannabis operation, including Health Canada licences, GACP certification, a fully owned processing facility and greenhouse, equipment, and a 14-acre cannabis-zoned property. The Company is now offering the business, licences, assets and property for sale. One of fewer than 20 EU-GMP certifications among 800+ Canadian LPs.

Well-established, fully licensed retail cannabis portfolio operating across high-visibility BC markets, projecting ~$3.6 million revenue in 2026 with increasing, recurring data monetization streams

An exceptional opportunity to acquire 100% of an established German GmbH specifically structured for the high-growth medical cannabis sector. The entity offers a lean, highly scalable infrastructure with all critical operational pillars—including a licensed packing/storage warehouse, fully verified GMP/GDP compliance, strategic supply chain partnerships, and advanced quality technology—positioned for immediate market acceleration.

Unique opportunity to invest in a pre-operational UK medical cannabis platform being established through a structured regulatory and licensing pathway, led by an experienced sector operator and set to operate all steps from import to patient.

Opportunity to acquire an active, scalable BC cultivation and processing business (standard-ready), EU-GMP design, and significant production upside, with the option to acquire industrial land and purpose-built facility with 1.5MW power @ $0.068 / kWh.

Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential

Purpose-built for high-efficiency patient acquisition and retention within the Canadian medical cannabis sector, this low-overhead, tech-enabled platform provides a high-margin gateway for LPs and healthcare practitioners seeking to scale their patient bases quickly. Designed with scalability in mind, the platform is poised to expand into adjacent care segments and international markets

Unique opportunity to acquire a leased, GACP-certified, 4,400 ft² licensed cultivation and processing facility located in a multi-unit industrial complex approximately ~1 hour west of Toronto, ON.

Pre-licensed and debt-free company in Portugal, offering a ready-to-build project on a 10,180 m² industrial-zoned plot for an asking price of €200,000, which saves you 1-2 years of typical licensing and development delays.

Fully operational, revenue-generating German cannabis group offers an ideal investment opportunity for firms seeking strategic entry, expansion, or synergy within the regulated cannabis, CBD, and industrial hemp markets across Germany and Europe

State-of-the-art manufacturing and extraction facility in Southern Italy, fully equipped for industrial processing, laboratory analysis, packaging, and secure storage. Ideal for cannabinoid extraction, R&D, or industrial biotech applications. Available for outright sale.

~20,000 ft.² wholly-owned, cultivation and processing facility with ~$3.9 million spent on the building for sale located 1 hr away from Montreal, QC

Opportunity to invest in fully turnkey, GMP-certified Jamaican pharmaceutical cannabis manufacturer positioned to expand in Brazil & launch in the US once rescheduling takes place. With pharma licensing, export permits & duty-free trade agreements, the company's near-shore facility is poised to lead both pharmaceutical & medical cannabis markets globally

Multiple profitable cannabis retail stores in Ottawa region, Pickering, Simcoe, and other locations for sale. Inquire for more information.

Unique opportunity to purchase a wholly-owned, pharmaceutical grade, 17,000 ft.² licensed cultivation and processing facility on 4.2 acres of land in NB

German pharmaceutical wholesaler, importer and exporter of medical cannabis offers ideal launch pad for new cannabis products into the German market

Highly-specialized, Swiss-German R&D firm first to market with disruptive, advanced medical inhaler for clean cannabis extracts seeks strategic funding partner

Uniquely-licensed supplier of exclusive, high-quality, cost-effective branded cannabis products via established medical clinic partnerships & UK pharmacy contracts. Poised for significant expansion in the UK and EU medical cannabis sectors!

The opportunity to begin this program is immediate and entirely turnkey. The Company is licensed by the Government of Portugal to import, export, cultivate and manufacture medical cannabis

Wholly owned, ∼150K ft.² licensed, hybrid greenhouse with support buildings sitting on 10 acres of land with production capability of 2,500-3,000 KG/yr

Seeking JV or sale of a 15,000+ ft.² licensed cannabis greenhouse sitting on a 3.5 acre fenced property in upstate New York

De-risked operations entering 5th year of cultivation. 6-acre cannabis farm with high-yielding supply of multi-strain, high-quality, high-THC, low cost-to-produce outdoor flower in SW Ontario